scispace - formally typeset
D

Dai Nishikawa

Publications -  4
Citations -  309

Dai Nishikawa is an academic researcher. The author has contributed to research in topics: Reverse transcriptase & Hepatitis C virus. The author has an hindex of 3, co-authored 4 publications receiving 271 citations.

Papers
More filters
Journal ArticleDOI

Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.

TL;DR: The amino acid-type fullerene derivative was the most efficient in human immunodeficiency virus-reverse transcriptase inhibition of hepatitis C virus RNA-dependent RNA polymerase inhibition.
Journal ArticleDOI

Antibacterial and antiproliferative activity of cationic fullerene derivatives.

TL;DR: The fullerene derivatives with a long alkyl chain did not show antibacterial activity, and the alkylated C(60)-bis(N,N-dimethylpyrrolidinium iodide derivatives inhibited bacteria and cancer cell growth effectively.
Journal ArticleDOI

Human Immunodeficiency Virus-Reverse Transcriptase Inhibition and Hepatitis C Virus RNA-Dependent RNA Polymerase Inhibition Activities of Fullerene Derivatives.

TL;DR: In this article, the authors examined the human immunodeficiency virus-reverse transcriptase and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of cationic, anionic, and amino acid-type fullerene derivatives.
Journal ArticleDOI

Antibacterial and Antiproliferative Activity of Cationic Fullerene Derivatives.

TL;DR: In this paper, the antibacterial and antiproliferative activities of alkylated C(60)-bis(N,N-dimethylpyrrolidinium iodide) derivatives were examined.